|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.940 EUR | -1.27% |
|
-2.02% | -1.27% |
| Capitalization | 23Cr 27Cr 22Cr 20Cr 38Cr 2.47TCr 41Cr 251.64Cr 99Cr 1.18TCr 102.22Cr 100.12Cr 4.31TCr | P/E ratio 2025 * |
9.24x | P/E ratio 2026 * | 8.08x |
|---|---|---|---|---|---|
| Enterprise value | 53Cr 61Cr 49Cr 46Cr 85Cr 5.54TCr 91Cr 563.36Cr 222.14Cr 2.64TCr 228.85Cr 224.14Cr 9.64TCr | EV / Sales 2025 * |
10.4x | EV / Sales 2026 * | 9.82x |
| Free-Float |
28.49% | Yield 2025 * |
7.22% | Yield 2026 * | 7.73% |
Last Transcript: Trade Estates REIC
| 1 day | -1.27% | ||
| 1 week | -2.02% | ||
| Current month | -1.27% | ||
| 1 month | -1.02% | ||
| 3 months | +9.60% | ||
| 6 months | +18.29% | ||
| Current year | -1.27% |
| 1 week | 1.89 | 1.98 | |
| 1 month | 1.89 | 2.03 | |
| Current year | 1.89 | 2.01 | |
| 1 year | 1.52 | 2.03 | |
| 3 years | 1.52 | 2.03 | |
| 5 years | 1.52 | 2.03 | |
| 10 years | 1.52 | 2.03 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Chris Aesopos
BRD | Director/Board Member | 59 | - |
| Director/Board Member | 73 | - | |
| Chairman | 66 | - |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.27% | -2.02% | +17.43% | - | 27Cr | ||
| +0.96% | +0.72% | +16.34% | +39.07% | 1.46TCr | ||
| +4.29% | +7.51% | +127.26% | +236.72% | 900.84Cr | ||
| -0.46% | -2.50% | +12.20% | +156.07% | 732.67Cr | ||
| +0.14% | +0.62% | +180.05% | +263.35% | 417.15Cr | ||
| +3.54% | +9.80% | +122.38% | +229.62% | 351.92Cr | ||
| 0.00% | -0.30% | +51.13% | +90.86% | 335.68Cr | ||
| +1.75% | -8.57% | +93.35% | +12.28% | 277.11Cr | ||
| +2.31% | -1.64% | +60.22% | +64.63% | 267.04Cr | ||
| +7.62% | +1.43% | +42.72% | +35.29% | 264.47Cr | ||
| Average | +1.89% | +0.95% | +72.31% | +125.32% | 503.62Cr | |
| Weighted average by Cap. | +1.85% | +1.50% | +66.82% | +126.95% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 5.06Cr 5.87Cr 4.71Cr 4.39Cr 8.16Cr 532.55Cr 8.78Cr 54Cr 21Cr 254.02Cr 22Cr 22Cr 927.56Cr | 5.56Cr 6.45Cr 5.18Cr 4.82Cr 8.97Cr 585.17Cr 9.65Cr 60Cr 23Cr 279.13Cr 24Cr 24Cr 1.02TCr |
| Net income | 2.49Cr 2.89Cr 2.32Cr 2.16Cr 4.02Cr 262.06Cr 4.32Cr 27Cr 11Cr 125Cr 11Cr 11Cr 456.45Cr | 2.86Cr 3.32Cr 2.66Cr 2.48Cr 4.61Cr 301.01Cr 4.97Cr 31Cr 12Cr 143.58Cr 12Cr 12Cr 524.27Cr |
| Net Debt | 29Cr 34Cr 27Cr 25Cr 47Cr 3.06TCr 51Cr 311.72Cr 122.91Cr 1.46TCr 126.63Cr 124.02Cr 5.34TCr | 31Cr 36Cr 29Cr 27Cr 50Cr 3.27TCr 54Cr 332.81Cr 131.23Cr 1.56TCr 135.2Cr 132.41Cr 5.7TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 16/26/16 | 1.940 € | -1.27% | 99,657 |
| 15/26/15 | 1.965 € | +0.26% | 1,05,949 |
| 14/26/14 | 1.960 € | +0.51% | 1,40,925 |
| 13/26/13 | 1.950 € | -1.02% | 36,174 |
| 12/26/12 | 1.970 € | -0.51% | 46,040 |
Delayed Quote Athens S.E., January 16, 2026 at 08:40 pm IST
More quotesTrader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.

Annual profits - Rate of surprise
- Stock Market
- Equities
- TRESTATES Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















